North America Opioids Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Opioids Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Opioids Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Opioids Market Regional Analysis

6.2 North America Opioids Market Revenue 2020-2030 (US$ Million)

6.3 North America Opioids Market Forecast Analysis

7. North America Opioids Market Analysis – by Product

7.1 Immediate Release Short Acting Opioid

7.1.1 Overview
7.1.2 Immediate Release Short Acting Opioid: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Extended Release Long Acting Opioid

7.2.1 Overview
7.2.2 Extended Release Long Acting Opioid: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Opioids Market Analysis – by Application

8.1 Pain Management

8.1.1 Overview
8.1.2 Pain Management: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Anesthesia

8.2.1 Overview
8.2.2 Anesthesia: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Diarrhea Suppression

8.3.1 Overview
8.3.2 Diarrhea Suppression: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.4 Cough Suppression

8.4.1 Overview
8.4.2 Cough Suppression: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.5 De-Addiction

8.5.1 Overview
8.5.2 De-Addiction: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Opioids Market Analysis – by Route of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Injectable

9.2.1 Overview
9.2.2 Injectable: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Transdermal Patch

9.3.1 Overview
9.3.2 Transdermal Patch: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. North America Opioids Market Analysis – by Distribution Channel

10.1 Hospital Pharmacies

10.1.1 Overview
10.1.2 Hospital Pharmacies: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Retail Pharmacies

10.2.1 Overview
10.2.2 Retail Pharmacies: North America Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. North America Opioids Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Opioids Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 North America Opioids Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 US: North America Opioids Market Breakdown, by Product
11.2.1.1.2 US: North America Opioids Market Breakdown, by Application
11.2.1.1.3 US: North America Opioids Market Breakdown, by Route of Administration
11.2.1.1.4 US: North America Opioids Market Breakdown, by Distribution Channel

11.2.1.2 Canada: North America Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Canada: North America Opioids Market Breakdown, by Product
11.2.1.2.2 Canada: North America Opioids Market Breakdown, by Application
11.2.1.2.3 Canada: North America Opioids Market Breakdown, by Route of Administration
11.2.1.2.4 Canada: North America Opioids Market Breakdown, by Distribution Channel

11.2.1.3 Mexico : North America Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 Mexico : North America Opioids Market Breakdown, by Product
11.2.1.3.2 Mexico : North America Opioids Market Breakdown, by Application
11.2.1.3.3 Mexico : North America Opioids Market Breakdown, by Route of Administration
11.2.1.3.4 Mexico : North America Opioids Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Purdue Pharma LP

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Endo International plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Mallinckrodt Plc

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Collegium Pharmaceutical Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Neuraxpharm Pharmaceuticals SL

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Hikma Pharmaceuticals Plc

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Rusan Pharma Ltd

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Trevena Inc

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Teva Pharmaceutical Industries Ltd

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Opioids Market